Sekisui Diagnostics

Sekisui Diagnostics is a well-established, global player in the in-vitro diagnostics (IVD) market, operating as a subsidiary of the Japanese conglomerate Sekisui Chemical Co., Ltd. The company's core business is built on a diversified portfolio spanning clinical chemistry reagents, point-of-care (POC) rapid tests and molecular diagnostics, specialty enzymes, and biopharma services. With a strong emphasis on accuracy and reliability, it leverages a significant manufacturing scale and a long-standing reputation to serve a broad customer base across the healthcare value chain. Its strategic focus includes enhancing laboratory efficiency and expanding its footprint in decentralized testing.

Portfolio of technologies including clinical chemistry & immunoassay reagents, point-of-care rapid tests & molecular diagnostics (Metrix system), specialty enzyme manufacturing, and blood collection tube materials.

Sekisui Diagnostics competes in a fragmented but top-heavy market. In clinical chemistry reagents, it competes with giants like Roche, Siemens Healthineers, and Beckman Coulter (Danaher). In point-of-care, it faces Abbott, QuidelOrtho, and Cepheid (Danaher). Its enzyme business competes with specialized suppliers like Thermo Fisher and Asahi Kasei.